SPRITAM 250 MG TABLET

levetiracetam
$10.2722per EA
High Outlier

Strength

250 mg/1

NDC

43485010160

Classification

Brand

Dosage Form

TABLET, FOR SUSPENSION

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

LEVETIRACETAM

Approval Type

New Drug (NDA)

FDA Application

NDA207958

On Market Since

2/5/2016

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

-0.6%

6M

-0.7%

1Y

-0.8%

3Y

N/A

5Y

N/A

All

-1.2%

Generic Alternatives

Save up to 21%

1 alternative • Same active ingredient